Areas in hectare of actual and potential productivity classes in study area. by Ibraheem A. H. Yousif (20565395)

The tangential force between two particles with different equivalent diameters for P3: (a) elastic tangential contact force; (b) viscous tangential contact force. by Yongfeng Zhu (7361045)

Comparative Summary of Characteristics with Statistically Significant Differences between the Two Classes Identified. by Ramón Ventura Roque Hernández (22766229)

Description of fold change of MiR-125b and Lnc THRIL among study groups. by Azza Elamir (13924199)

Subjects:

Selected functional classes of the significantly differentially expressed proteins under heat stress. by Asia Perveen (17471895)

Number of significantly significant (P < 0.05) differentially abundant (SSDA) proteins showing increased or decreased activity (fold change +/- 1.5-fold) relative to time 0 following storage at 9°C or 20°C of infective juveniles of <i>S</i>.... by Peter E. Lillis (12368582)

“…<p>Number of significantly significant (P < 0.05) differentially abundant (SSDA) proteins showing increased or decreased activity (fold change +/- 1.5-fold) relative to time 0 following storage at 9°C or 20°C of infective juveniles of <i>S</i>. …”

Prevalence of potentially pathogenic genera of veterinary significance per sample group. by Khethiwe Mtshali (13550211)

Subjects:

Transcriptional and translational markers of syncytialization and biochemical differentiation are significantly decreased by rotenone. by O’Llenecia S. Walker (8486163)

The normal force between two particles with De = 6.30 mm for different aspect ratios and sphericities: (a) hertz normal contact force; (b) normal viscous contact force. by Yongfeng Zhu (7361045)

The tangential force between two particles with different aspect ratios and sphericities for De = 6.30 mm: (a) elastic tangential contact force; (b) viscous tangential contact forc... by Yongfeng Zhu (7361045)

Development of a First-in-Class DNMT1/HDAC Inhibitor with Improved Therapeutic Potential and Potentiated Antitumor Immunity by Yingjie Chang (19654231)

Subjects:

Development of a First-in-Class DNMT1/HDAC Inhibitor with Improved Therapeutic Potential and Potentiated Antitumor Immunity by Yingjie Chang (19654231)

Subjects:

Quantification of immune-associated gene expression (fold) in LPS-stimulated RAW264.7 cells. by A-yeong Jang (9500111)

Mean accuracy and variance comparison with statistical significance. by Yaxun Jia (12000572)

Subjects:

Negative ion mode significant differential metabolites (Fold Change greater than 2 or less than 0.5). by Peng-fei Han (694841)

Positive ion mode significant differential metabolites (Fold Change greater than 2 or less than 0.5). by Peng-fei Han (694841)

Settling time for changes in the median of the Folded Normal distribution. by Ariel Burman (20329776)

The 160 differentially expressed proteins significantly elevated in the severe injury group compared to the mild injury group and their folding changes. by Huiyang Jia (14444661)

Class predictions. by Paweł Pstrokoński (21238139)

Class differences in the drug population of human atrial cell models (31,842 in the Class III and 28,757 in the non-Class III). by Jieyun Bai (7525148)